#104 – Dosing Consult: Rifampin Part 1
Breakpoints4 Loka 2024

#104 – Dosing Consult: Rifampin Part 1

In this episode of Breakpoints’ Dosing Consult series, Drs. Chuck Peloquin and Gerry Davies join Dr. Megan Klatt to discuss rifampin dosing for mycobacterial infections. Hear from the experts on if higher doses are really better, toxicity thresholds, and the role of alternative rifamycins for patients with MTB and NTMs.

Learn more about the Society of Infectious Diseases Pharmacists: https://sidp.org/About X: @SIDPharm (https://twitter.com/SIDPharm) Instagram: @SIDPharm (https://www.instagram.com/sidpharm/) Facebook: https://www.facebook.com/sidprx LinkedIn: https://www.linkedin.com/company/sidp

References:

  1. Efficacy and Safety of High-Dose Rifampin in Pulmonary Tuberculosis. A Randomized Controlled Trial. Am J Respir Crit Care Med. 2018 Sep 1;198(5):657-666. doi: 10.1164/rccm.201712-2524OC.
  2. Rifampin vs. rifapentine: what is the preferred rifamycin for tuberculosis? Expert Rev Clin Pharmacol. 2017 Oct;10(10):1027-1036. doi: 10.1080/17512433.2017.1366311.
  3. Rifabutin for treating pulmonary tuberculosis. Cochrane Database Syst Rev. 2007 Oct; 2007(4): CD005159. doi: 10.1002/14651858.CD005159.pub2.
  4. Implementation of Bedaquiline, Pretomanid, and Linezolid in the United States: Experience Using a Novel All-Oral Treatment Regimen for Treatment of Rifampin-Resistant or Rifampin-Intolerant Tuberculosis Disease. Clin Infect Dis. 2023 Oct 5;77(7):1053-1062. doi: 10.1093/cid/ciad312.

This podcast is powered by Pinecast.

Tämä jakso on lisätty Podme-palveluun avoimen RSS-syötteen kautta eikä se ole Podmen omaa tuotantoa. Siksi jakso saattaa sisältää mainontaa.

Jaksot(134)

#46 – A Nefarious Orchestra: Gram-Negative Resistance Mechanisms Part 1

#46 – A Nefarious Orchestra: Gram-Negative Resistance Mechanisms Part 1

Mechanisms of antibiotic resistance help us understand and recognize antibiotic susceptibility patterns that don't make sense. Robert Bonomo and Ryan Shields (@ryankshields) join Erin McCreary (@ErinM...

22 Loka 20210s

#45 – Expectation vs. Reality: An Insider look at the OVERCOME and MERINO-2 trials

#45 – Expectation vs. Reality: An Insider look at the OVERCOME and MERINO-2 trials

Pathogen-directed trials are among the most important trials that clinicians need to guide therapy but are also incredibly difficult to design and enroll. Rachel Britt (@RachelBPharmD) gets a behind-...

24 Syys 20210s

#44 – The VaxScene, a review of the COVID-19 vaccine landscape in the US with a focus on equitable distribution and vaccine hesitancy

#44 – The VaxScene, a review of the COVID-19 vaccine landscape in the US with a focus on equitable distribution and vaccine hesitancy

Jacinda Abdul-Mutakabbir (@jayCdoesID) and Jeannette Bouchard (@jlbouchard001) join Erin McCreary (@ErinMcCreary) to discuss COVID vaccines, including access to, confidence in, and hesitancy around th...

17 Syys 20210s

#43 – Level Up: Implementation of Beta-lactam Therapeutic Drug Monitoring

#43 – Level Up: Implementation of Beta-lactam Therapeutic Drug Monitoring

Erin McCreary (@erinmccreary) reviews clinical data and implementation strategies for therapeutic drug monitoring of beta-lactam antibiotics with Veena Venugopalan (@Veena_PharmD), Joseph Kuti, Jason ...

27 Elo 20211h 2min

#42 – The Level is in the Details:  Beta-lactam Therapeutic Drug Monitoring

#42 – The Level is in the Details: Beta-lactam Therapeutic Drug Monitoring

Erin McCreary (@erinmccreary) discusses clinical rationale behind therapeutic drug monitoring of beta-lactam antibiotics with Veena Venugopalan (@Veena_PharmD), Joseph Kuti, Jason Roberts (@jasonrober...

20 Elo 202155min

#41 – The Gray Zone: Antimicrobial Stewardship in Immunocompromised Hosts

#41 – The Gray Zone: Antimicrobial Stewardship in Immunocompromised Hosts

Promoting evidence-based antimicrobial stewardship for patients with immunocompromising conditions can be tricky when they’re often excluded from clinical studies. Dr. Zahra Kassamali Escobar (@ZKEPha...

16 Heinä 20210s

#40 – Breakpoints Talks Breakpoints: Microbiology Labs and Stewardship

#40 – Breakpoints Talks Breakpoints: Microbiology Labs and Stewardship

In this episode, host Dr. Erin McCreary (@erinmccreary) talks all things micro labs and stewardship with Dr. Romney Humphries (@romneyinla), Dr. Mary Hutton (@m3rkat), and Dr. Joseph Lutgring. From ca...

18 Kesä 20211h 13min

#39 – A Little More on the Littles: What Adults Should Know about ID Pediatrics

#39 – A Little More on the Littles: What Adults Should Know about ID Pediatrics

In this rapidfire episode Dr. Erin Weslander (@littlebugdrug), Dr. Laura Bio (@StanfordPedsASP), and Dr. Diana Yu (@dyupharmd) reveal their super-secret ID toolkit to figure out dosing and approaches ...

21 Touko 202117min

Suosittua kategoriassa Koulutus

rss-murhan-anatomia
psykopodiaa-podcast
voi-hyvin-meditaatiot-2
adhd-podi
rss-rahamania
rss-liian-kuuma-peruna
rss-vapaudu-voimaasi
psykologia
rss-laadukasta-ensihoitoa
rss-narsisti
kesken
rss-valo-minussa-2
rss-arkea-ja-aurinkoa-podcast-espanjasta
rahapuhetta
rss-niinku-asia-on
rss-keskeneraiset-aidit
rss-naistalk
rss-duodecim-lehti
rss-tfa-8020-podcast
rss-luonnollinen-synnytys-podcast